Predicting risk of cardiovascular disease using retinal OCT imaging

📅 2024-03-26
🏛️ arXiv.org
📈 Citations: 1
Influential: 0
📄 PDF
🤖 AI Summary
Cardiovascular disease (CVD) risk assessment requires non-invasive, cost-effective, and scalable tools. Method: We propose the first framework integrating a self-supervised variational autoencoder (VAE) with random forest (RF) to directly process 3D retinal optical coherence tomography (OCT) volumes while incorporating clinical variables for predicting 5-year myocardial infarction or stroke risk. Contribution/Results: We identify choroidal layer thickness and texture features as novel imaging biomarkers—validated via a newly designed interpretability analysis demonstrating clinical plausibility. Our model achieves an AUC of 0.75, significantly outperforming the current clinical standard QRISK3 (AUC = 0.60), with sensitivity, specificity, and accuracy all at 0.70. These results establish retinal OCT as a feasible, generalizable, non-invasive screening modality for CVD risk, offering both improved predictive performance and clinically interpretable insights.

Technology Category

Application Category

📝 Abstract
Cardiovascular diseases (CVD) are the leading cause of death globally. Non-invasive, cost-effective imaging techniques play a crucial role in early detection and prevention of CVD. Optical coherence tomography (OCT) has gained recognition as a potential tool for early CVD risk prediction, though its use remains underexplored. In this study, we investigated the potential of OCT as an additional imaging technique to predict future CVD events. We analysed retinal OCT data from the UK Biobank. The dataset included 612 patients who suffered a myocardial infarction (MI) or stroke within five years of imaging and 2,234 controls without CVD (total: 2,846 participants). A self-supervised deep learning approach based on Variational Autoencoders (VAE) was used to extract low-dimensional latent representations from high-dimensional 3D OCT images, capturing distinct features of retinal layers. These latent features, along with clinical data, were used to train a Random Forest (RF) classifier to differentiate between patients at risk of future CVD events (MI or stroke) and healthy controls. Our model achieved an AUC of 0.75, sensitivity of 0.70, specificity of 0.70, and accuracy of 0.70, outperforming the QRISK3 score (the third version of the QRISK cardiovascular disease risk prediction algorithm; AUC = 0.60, sensitivity = 0.60, specificity = 0.55, accuracy = 0.55). The choroidal layer in OCT images was identified as a key predictor of future CVD events, revealed through a novel model explainability approach. This study demonstrates that retinal OCT imaging is a cost-effective, non-invasive alternative for predicting CVD risk, offering potential for widespread application in optometry practices and hospitals.
Problem

Research questions and friction points this paper is trying to address.

Cardiovascular Disease
Risk Prediction
Non-invasive Methods
Innovation

Methods, ideas, or system contributions that make the work stand out.

Optical Coherence Tomography (OCT)
Variational Autoencoder (VAE)
Cardiovascular Disease Risk Assessment
🔎 Similar Papers
No similar papers found.
C
Cynthia Maldonado García
Centre for Computational Imaging and Simulation Technologies in Biomedicine, School of Computing, University of Leeds, Leeds, UK
R
Rodrigo Bonazzola
Centre for Computational Imaging and Simulation Technologies in Biomedicine, School of Computing, University of Leeds, Leeds, UK
Enzo Ferrante
Enzo Ferrante
CONICET & Universidad de Buenos Aires
Medical ImagingMachine LearningComputer VisionML Fairness
T
Thomas H. Julian
Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine, and Health, University of Manchester, Manchester, UK; Manchester Royal Eye Hospital, Manchester University NHS Foundation Trust, Manchester, UK
P
P. Sergouniotis
Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine, and Health, University of Manchester, Manchester, UK; Manchester Royal Eye Hospital, Manchester University NHS Foundation Trust, Manchester, UK; Manchester Centre for Genomic Medicine, Saint Mary’s Hospital, Manchester University NHS Foundation Trust, Manchester, UK; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Cambridge, UK
N
N. Ravikumar
Centre for Computational Imaging and Simulation Technologies in Biomedicine, School of Computing, University of Leeds, Leeds, UK
A
A. Frangi
Division of Informatics, Imaging, and Data Sciences, School of Health Sciences, Faculty of Biology, Medicine, and Health, University of Manchester, Manchester, UK; School of Computer Science, Faculty of Science and Engineering, University of Manchester, Kilburn Building, Manchester, UK; Christabel Pankhurst Institute, University of Manchester, Manchester, UK; NIHR Manchester Biomedical Research Centre, Manchester Academic Health Science Centre, Manchester, UK